| |
 |
|
Estracure, Inc.
Estracure is a Montreal-based company currently developing next-generation coronary stenting products based on proprietary estrogen-based technologies that minimize restenosis and potentially prevent progression of coronary lesions. With safety an increasingly important consideration with drug-eluting stents, Estracure's novel technology with its enhanced safety profile holds promise as a potential replacement for current-generation drug-eluting stents.
Estracure Inc.
Research Centre
Montreal Heart Institute
5000, Bélanger St. East
Montreal,
Quebec
Canada H1T 1C8
|
